FDA Adverse Event Injury Summary report: N

NXSTAGE SYSTEM ONE

MDR report key: 1150498 · Received September 4, 2008

Report

Report Number
3003464075-2008-00412
Event Type
Injury
Date Received
September 4, 2008
Date of Event
August 9, 2008
Report Date
August 9, 2008
Manufacturer
NXSTAGE MEDICAL, INC.
Product Code
KDI
PMA / PMN Number
K050525
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE REPORTED BLOOD LOSS IS ATTRIBUTED TO THE PATIENT'S NEEDLE DISLODGING DURING TREATMENT, AND NOT PERFORMING RINSEBACK OF THE PATIENT'S BLOOD. THE USER'S GUIDE STATES THAT THE NXSTAGE CYCLER MAY NOT SENSE SLOW FLUID OR BLOOD LEAKS RESULTING FROM LOOSE CONNECTIONS, FAULTY COMPONENTS, VENOUS ACCESS DISCONNECTION OR OTHER POTENTIAL CAUSES. LEAKING FLUIDS COULD LEAD TO BLOOD LOSS, INJURY, OR DEATH. LEAKING FLUIDS COULD ALSO CAUSE A PERSON TO SLIP OR FALL. ALWAYS TIGHTEN AND RECHECK PATIENT VASCULAR ACCESS AND ALL FLUID LINES, CONNECTIONS, CAPS AND CLAMPS. SECURE THE BLOOD ACCESS DEVICE TO THE PATIENT. VISUALLY INSPECT THE SYSTEM PERIODICALLY FOR EVIDENCE OF LEAKS. TERMINATE TREATMENT IF LEAK CANNOT BE RESOLVED. A DIRECT CORRELATION BETWEEN NXSTAGE SYSTEM ONE AND THE REPORTED BLOOD LOSS CANNOT BE ESTABLISHED. FACILITY STAFF HAS BEEN NOTIFIED. NXSTAGE MEDICAL CONSIDERS THIS REPORT CLOSED. NO ADDITIONAL INFORMATION WILL BE PROVIDED.

Description of Event or Problem · 1

THIS REPORT IS BEING FILED AS AN ADVERSE EVENT SOLELY TO COMPLY WITH THE FDA'S BLOOD LOSS POLICY. THE PATIENT'S NEEDLE DISLODGED DURING A ROUTINE HEMODIALYSIS TREATMENT. TREATMENT WAS DISCONTINUED WITHOUT RINSEBACK, RESULTING IN A BLOOD LOSS OF 190CC. THE ADDITIONAL BLOOD LOSS AMOUNT FROM THE NEEDLE DISLODGEMENT WAS NOT KNOWN BUT DESCRIBED AS "NOT VERY MUCH". NO MEDICAL INTERVENTION WAS REQUIRED SPECIFICALLY TO ADDRESS THE BLOOD LOSS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NXSTAGE SYSTEM ONE HIGH PERMEABILITY HEMODIALYSIS SYSTEM KDI NXSTAGE MEDICAL, INC. CAR-170 UNK

Patients

Seq Age Sex Outcome Treatment
1 64 YR Other